Insider filing · NTRA
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER
profile →
Natera, Inc.
NTRA · Healthcare · 229 filings in 24 months
ticker →
Michael Burkes Brophy sold $1.1M of Natera (NTRA)
Executed Jan 29 2025, disclosed Jan 31 2025, 2 days later.
Value, as filed
$1.1M
6,218 sh across 3 lots
Executed
Jan 29 2025
the trade date, as filed
Disclosed
Jan 31 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MBMichael Burkes Brophy (CHIEF FINANCIAL OFFICER) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Natera, Inc. (NTRA). The largest single filing was $14.6M of NTRA (61,123 sh across 3 lots, as filed), executed Jan 20.
The name
NTRAHealthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael Burkes Brophy in NTRA
NTRASALE
Natera, Inc.
$311K787 sh across 2 lots
Exec Nov 2
Filed Nov 4 · 9:35 PM ET NTRASALE Natera, Inc. $1.3M
3,084 sh across 3 lots
Exec Oct 28
Filed Oct 30 · 9:35 PM ET NTRASALE Natera, Inc. $828K
1,979 sh across 2 lots
Exec Oct 27
Filed Oct 29 · 9:35 PM ET NTRASALE Natera, Inc. $131K
478 sh × $274.22
Exec Aug 4
Filed Aug 5 · 9:35 PM ET NTRASALE Natera, Inc. $1.2M
4,894 sh across 4 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET NTRASALE Natera, Inc. $101K
482 sh × $210.49
Exec May 4
Filed May 5 · 5:30 PM ET NTRASALE Natera, Inc. $809K
4,063 sh across 4 lots
Exec Apr 27
Filed Apr 29 · 5:30 PM ET NTRASALE Natera, Inc. $160K
785 sh × $204.13
Exec Mar 10
Filed Mar 11 · 5:30 PM ET